2023 annual financial data
NervGen Pharma 2023 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -17,778,208 CAD and net income was -22,384,007 CAD.
Operating cash flow was -11,296,546 CAD.
Get free NervGen Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 CAD
- Operating income
- -17,778,208 CAD
- Net income
- -22,384,007 CAD
- Operating cash flow
- -11,296,546 CAD